Thomas Christély
Chief Executive Officer at Atugen AG
Network origin in Thomas Christély first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Metriopharm AG
 Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland.
14
| Holding Company | Pharmaceuticals: Major | 14 |
Atugen AG
 Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Thomas Christély via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Somatogen, Inc.
 Somatogen, Inc. BiotechnologyHealth Technology Somatogen, Inc. develops specialty oxygen therapeutics. It is engaged in the research, clinical development and commercialization of genetically engineered recombinant human hemoglobin-based products. The company is located in Boulder, CO. | Biotechnology | Corporate Officer/Principal | |
| AFFYMETRIX, INC. | Medical Specialties | Corporate Officer/Principal | |
| DELTAGEN INC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Millenium Biologix Corp.
 Millenium Biologix Corp. BiotechnologyHealth Technology Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON. | Biotechnology | Director/Board Member | |
| L-KONZEPT HOLDING AG | Real Estate Development | Chairman | |
| CEA INDUSTRIES INC. | Trucks/Construction/Farm Machinery | Corporate Officer/Principal | |
TVM Capital GmbH
 TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Investment Managers | Private Equity Investor | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| MS INDUSTRIE AG | Electronic Equipment/Instruments | Chief Executive Officer | |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Tulane University (Louisiana) | College/University | Graduate Degree | |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Investment Trusts/Mutual Funds | Chief Tech/Sci/R&D Officer | |
| The University of Colorado | College/University | Masters Business Admin | |
| BIOFRONTERA AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Xantos AG
 Xantos AG Pharmaceuticals: MajorHealth Technology Xantos AG is a functional biology and drug discovery company developing biopharmaceuticals in the areas of cancer and metabolic diseases. Its business model is to develop drug discovery pipelines based on the validated targets and leads generated by its proprietary through target identification and validation system and to form indication specific joint research and development collaborations with pharmaceutical and biotechnology companies. It also offers customers its proprietary technology and cDNA/siRNA screening tools for research service deals. The company is headquartered in Munich, Germany. | Pharmaceuticals: Major | Founder | |
| Freie Universität Berlin | College/University | Doctorate Degree | |
GCI BridgeCapital AG
 GCI BridgeCapital AG Financial ConglomeratesFinance GCI BridgeCapital AG operates as an investment firm engaged in investment management, portfolio management, private equity investment and tax consulting. The company is based in Munich, Germany. | Financial Conglomerates | Director/Board Member | |
| University of Regensburg | College/University | Doctorate Degree | |
| Max-Planck-Institute for Molecular Genetics | College/University | Chief Tech/Sci/R&D Officer | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Wuerzburg Schweinfurt University of Applied Sciences | College/University | Undergraduate Degree | |
Clifford Chance Pünder (Germany)
 Clifford Chance Pünder (Germany) Miscellaneous Commercial ServicesCommercial Services Part of Clifford Chance LLP, Clifford Chance Pünder (Germany) is a company based in Frankfurt am Main, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| RINGMETALL SE | Industrial Machinery | Director/Board Member | |
SuppreMol GmbH
 SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | President | |
GCI Management Consulting GmbH
 GCI Management Consulting GmbH Investment ManagersFinance GCI Management Consulting GmbH operates as a consulting company. It offers services to the entrepreneurs and managers in mid-size companies as well as in corporate entities. The company was founded in 1991 and is headquartered in Munich, Germany. | Investment Managers | Chief Executive Officer | |
Vakzine Projekt Management GmbH
 Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Pharmaceuticals: Major | Chairman | |
| UMT UNITED MOBILITY TECHNOLOGY AG | Semiconductors | Director/Board Member | |
| GSM Industries GmbH | Chief Investment Officer | ||
GCI Management GmbH
 GCI Management GmbH Miscellaneous Commercial ServicesCommercial Services GCI Management GmbH provides management consulting services. The CEO of the Austrian company is Markus W. Wenner. | Miscellaneous Commercial Services | Chief Executive Officer | |
| TELESERVICE AG | Specialty Telecommunications | Director/Board Member | |
BioMedion GmbH
 BioMedion GmbH Data Processing ServicesTechnology Services BioMedion GmbH provides intelligent data supply chain solutions for healthcare, research, and pharma. The company is based in Berlin, Germany, and has subsidiaries in Germany. The German company's product, neuronos, is preferred for GxP data. The company offers iRAW, iPQM, iTMF, and iRCS solutions. The company was founded by Ekkehard Brysch, and the CEOs are Andreas Suchanek and Dirk Aulike. | Data Processing Services | Founder | |
Tellco Holding AG
 Tellco Holding AG MiscellaneousMiscellaneous Tellco Holding AG engages in the acquisition, sale, holding, and management of participating interests in domestic and foreign companies. The company is headquartered in Schwyz, Switzerland. | Miscellaneous | Director/Board Member | |
Dynawert AG
 Dynawert AG Industrial MachineryProducer Manufacturing Dynawert AG manufactures sewage ejectors, pump stations, and submersible sewage pumps. The private company is based in Munich, Germany. | Industrial Machinery | Chairman | |
| WomenWeb AG | Chairman | ||
| Teleservice Management AG | Chairman | ||
| eventa AG | Chairman | ||
| MuM Industriebeteiligungen GmbH | President | ||
WERCO Trade AG
 WERCO Trade AG Wholesale DistributorsDistribution Services WERCO Trade AG is a Swiss company that operates in the trading industry. The private company is based in Steinhausen, Switzerland. The company's focus is on identifying challenges, reacting quickly, and delivering precise performance. | Wholesale Distributors | Director/Board Member | |
| SGRA Holding AG | Chairman | ||
| WOLFTANK-ADISA HOLDING AG | Investment Managers | Chairman | |
| TRAUMHAUS AG | Homebuilding | Chairman | |
| AIFINYO AG | Finance/Rental/Leasing | Director/Board Member | |
| swissVR | Corporate Officer/Principal | ||
Pantherna Therapeutics GmbH
 Pantherna Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Pantherna Therapeutics GmbH enages in developing of therapeutics for vascular diseases. The company is headquartered in Hennigsdorf, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
| DARWIN AG | Biotechnology | Corporate Officer/Principal |
Statistics
International
| Germany | 31 |
| United States | 12 |
| Switzerland | 5 |
| Austria | 3 |
| Canada | 2 |
Sectoral
| Health Technology | 12 |
| Finance | 9 |
| Consumer Services | 8 |
| Commercial Services | 7 |
| Producer Manufacturing | 4 |
Operational
| Director/Board Member | 76 |
| Chairman | 35 |
| Corporate Officer/Principal | 26 |
| Founder | 13 |
| Chief Executive Officer | 12 |
Most connected contacts
| Insiders | |
|---|---|
| Jeremy Curnock-Cook | 60 |
| Markus W. Wenner | 23 |
| Rudolf Stäger | 16 |
| Joerg Gruber | 13 |
| David W. Traylor | 9 |
| Peter Buckel | 8 |
| Bernd O. Wetzel | 8 |
| Klaus Giese | 7 |
| Ulrich G. Traugott | 5 |
| Ekkehard Brysch | 3 |
| Yme Alkema | 3 |
| Werner Wolf | 3 |
| Wolfgang Brysch | 1 |
| Eva Brysch | 1 |
| Ralf Haubert | 1 |
- Stock Market
- Insiders
- Thomas Christély
- Company connections
